Cargando…
Circulating Fibroblast Growth Factor-23 is Associated with Cardiovascular Prognosis and Graft Function in Renal Transplant Recipients
Purpose The aim of this study was to evaluate the relationship between Fibroblast Growth Factor-23 (FGF23) serum levels and cardiovascular disease and early graft failure in renal transplant recipients. Methods This cross-sectional study was conducted on renal transplant recipients followed by our...
Autores principales: | Algul Durak, Beyza, Karakan, Mine Sebnem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105230/ https://www.ncbi.nlm.nih.gov/pubmed/32257685 http://dx.doi.org/10.7759/cureus.7140 |
Ejemplares similares
-
The Comparison of QTc Dispersion Between Renal Transplant Recipients and Healthy Individuals
por: Durak, Musa Ilker, et al.
Publicado: (2022) -
Do Lifestyle Changes of Renal Transplant Recipients During the Pandemic Reduce the Risk of Coronavirus Disease 2019?
por: Hasanoglu, Imran, et al.
Publicado: (2020) -
Does neutrophil to lymphocyte ratio demonstrate deterioration in renal function?
por: Tonyali, Senol, et al.
Publicado: (2018) -
Influence of lipid profile and statin administration on arterial stiffness in renal transplant recipients
por: Heleniak, Zbigniew T., et al.
Publicado: (2022) -
Fibroblast growth factor 23 in children with or without heart failure: a prospective study
por: Elzayat, Rania Salah, et al.
Publicado: (2023)